JPWM
CRBU icon

Jamison Private Wealth Management’s Caribou Biosciences CRBU Stock Holding History

Jamison Private Wealth Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-188
Closed -$369 – 257
2024
Q3 		$369 Hold
188
– – ﹤0.01% 441
2024
Q2 		$309 Hold
188
– – ﹤0.01% 412
2024
Q1 		$967 Hold
188
– – ﹤0.01% 428
2023
Q4 		$1.08K Hold
188
– – ﹤0.01% 380
2023
Q3 		$899 Buy
+188
New +$1.17K ﹤0.01% 377

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jamison Private Wealth Management's CRBU Position: Q4 2024 in Review

Jamison Private Wealth Management sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 188 shares — an estimated $369 sold.

Jamison Private Wealth Management first reported a position in CRBU in Q3 2023 and held it in 5 quarters. The position peaked at $1.08K in Q4 2023. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Jamison Private Wealth Management reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Jamison Private Wealth Management sold 188 Caribou Biosciences shares in Q4 2024, an estimated $369.
  • Jamison Private Wealth Management first reported a position in Caribou Biosciences in Q3 2023 and held it in 5 quarters.
  • Jamison Private Wealth Management's Caribou Biosciences position peaked at $1.08K in Q4 2023.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Jamison Private Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.